![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](at2001contents.gif)
Acta Cryst. (2006). E62, o446-o448 [ doi:10.1107/S160053680504256X ]
Abstract: This study of the title compound, C14H9F3N4O, is part of a series of structural investigations of cyclooxygenase-2 (COX-2) inhibitors containing 1,3-diarylpyrazole derivatives. The crystal structure is stabilized by intermolecular N-H
O and C-H
F hydrogen-bonding interactions.
Online 7 January 2006
Copyright © International Union of Crystallography
IUCr Webmaster